Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 625.00 | 414.82 | 848.00 | 884.25 | 0.9590 | 0.9248 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 615.00 | 884.25 | 0.6955 | 0.4342 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 414.82 | 337.00 | 884.25 | 0.3811 | -0.1733 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 666.00 | 884.25 | 0.7532 | 0.5428 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 625.00 | 414.82 | 1114.00 | 884.25 | 1.2598 | 1.4711 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 1030.00 | 884.25 | 1.1648 | 1.2999 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 625.00 | 414.82 | 788.00 | 884.25 | 0.8912 | 0.7997 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 625.00 | 414.82 | 409.00 | 884.25 | 0.4625 | -0.0129 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 625.00 | 414.82 | 575.00 | 884.25 | 0.6503 | 0.3486 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 1171.00 | 884.25 | 1.3243 | 1.5866 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 954.00 | 884.25 | 1.0789 | 1.1440 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 414.82 | 909.00 | 884.25 | 1.0280 | 1.0512 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 625.00 | 414.82 | 601.00 | 884.25 | 0.6797 | 0.4043 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 630.00 | 884.25 | 0.7125 | 0.4662 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 787.00 | 884.25 | 0.8900 | 0.7976 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 625.00 | 414.82 | 432.00 | 884.25 | 0.4886 | 0.0379 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 820.00 | 884.25 | 0.9273 | 0.8665 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 838.00 | 884.25 | 0.9477 | 0.9040 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 891.00 | 884.25 | 1.0076 | 1.0140 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 625.00 | 414.82 | 450.00 | 884.25 | 0.5089 | 0.0774 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 879.00 | 884.25 | 0.9941 | 0.9891 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1761.00 | 1955.00 | 0.9008 | 0.8377 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1714.00 | 1955.00 | 0.8767 | 0.7979 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 845.00 | 1955.00 | 0.4322 | 0.0141 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 1250.00 | 830.55 | 1680.00 | 1955.00 | 0.8593 | 0.7690 |